GARDEN CITY, NY, Nov. 12, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) ("ProPhase” or the "Company”), a next-generation biotech, genomics and diagnostics company, today announced the ...

ProPhase Labs, Inc. (PRPH) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.30 per share a year ago. These ...

GARDEN CITY, NY, Nov. 12, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and ...

ProPhase anticipates significant sequential improvement in revenues and EBITDA in Q4 2024, and beyond, driven by strategic advancements across its subsidiaries. The company remains financially ...

GARDEN CITY, NY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the "Company” or "ProPhase”), a next generation biotech, genomics, and diagnostics company, today announced the ...

Introduces DNA Expand Subscription Platform to Enrich Existing DNA Ancestry Data with Comprehensive Health Insights GARDEN CITY, NY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: ...

Then, at the end of the year, the magazine's photo editors select "the most stunning photos" taken by its photographers for its annual Pictures of the Year issue. This year, 20 pictures were ...

As of November 19, 2024, ProPhase Labs, Inc. had a $18.1 million market capitalization, putting it in the 10th percentile of companies in the Pharmaceuticals industry. ProPhase Labs, Inc. does not ...

And now, Nat Geo has revealed the 2024 Pictures of the Year, choosing from more than 2 million photos. "We really want to capture the diversity of the world that our photographers are seeing ...